Table 2: Statistical analysis.
|
|
n=15 (%) |
5 years EFS |
P (EFS) |
5 years OS |
p (OS) |
|
Primary tumor size |
|
|
|
|
|
|
<5cm |
5
(33.3%) |
99% |
0.3582 |
99% |
0.5271 |
|
>5cm |
10
(66.7%) |
80% |
|
98.5% |
|
|
Site |
|
|
|
|
|
|
Limbs |
10
(66.7%) |
78% |
0.5546 |
89.5% |
0.7575 |
|
Axial |
4
(26.7%) |
99.5% |
|
99% |
|
|
Other |
1
(6.6%) |
- |
|
- |
|
|
IRS group |
|
|
0.5546 |
|
0.7575 |
|
I |
2
(13.3%) |
- |
|
- |
|
|
II |
4
(26.7%) |
99% |
|
99.5% |
|
|
III |
9
(60%) |
75% |
|
89.5% |
|
|
Best surgery at any time |
|
|
0.2324 |
|
0.5134 |
|
R0 |
5
(33.3%) |
98.5% |
|
99% |
|
|
R1 |
4
(26.7%) |
98.5% |
|
99.5% |
|
|
R2
/ Biopsy |
6
(40%) |
67% |
|
83.5% |
|
|
Response to CHT |
n= 8 |
0.009 |
|
|
0.0113 |
|
CR |
3
(20%) |
99% |
|
99% |
|
|
PR |
3
(20%) |
99% |
|
99% |
|
|
SD |
1
(6.6%) |
0% |
|
0% |
|
|
PD |
1
(6.6%) |
0% |
|
99% |
|
|
No
CHT |
7
(46.7%) |
99% |
|
99% |
|
CHT:
Chemotherapy, CR: Complete Remission; PR: Partial Response; SD: Stable Disease;
PD: Progressive Disease; EFS: Event Free survival OS: Overall Survival.